Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Valproic Acid | 3 | 2021 | 35 | 0.880 |
Why?
|
| Symporters | 1 | 2021 | 17 | 0.770 |
Why?
|
| Metformin | 1 | 2021 | 65 | 0.710 |
Why?
|
| Epilepsy | 1 | 2021 | 190 | 0.620 |
Why?
|
| Chromosome Disorders | 1 | 2017 | 40 | 0.600 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 131 | 0.580 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 549 | 0.480 |
Why?
|
| Suicidal Ideation | 3 | 2020 | 97 | 0.440 |
Why?
|
| Depressive Disorder | 4 | 2020 | 369 | 0.320 |
Why?
|
| Bipolar Disorder | 4 | 2021 | 208 | 0.300 |
Why?
|
| Neoplasms | 1 | 2017 | 1347 | 0.290 |
Why?
|
| Suicide, Attempted | 2 | 2017 | 77 | 0.270 |
Why?
|
| Adult | 12 | 2021 | 14279 | 0.200 |
Why?
|
| Pyruvates | 1 | 2021 | 1 | 0.190 |
Why?
|
| Dicarboxylic Acid Transporters | 1 | 2021 | 1 | 0.190 |
Why?
|
| Citrates | 1 | 2021 | 11 | 0.190 |
Why?
|
| Electroconvulsive Therapy | 1 | 2001 | 24 | 0.190 |
Why?
|
| Food Deprivation | 1 | 2021 | 29 | 0.190 |
Why?
|
| Lactates | 1 | 2021 | 31 | 0.190 |
Why?
|
| Electroencephalography | 2 | 2017 | 359 | 0.190 |
Why?
|
| Tooth Abnormalities | 1 | 2021 | 11 | 0.190 |
Why?
|
| Drosophila Proteins | 1 | 2021 | 29 | 0.190 |
Why?
|
| Ammonia | 1 | 2021 | 72 | 0.190 |
Why?
|
| Heterozygote | 1 | 2021 | 88 | 0.190 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 97 | 0.190 |
Why?
|
| Point Mutation | 1 | 2021 | 71 | 0.190 |
Why?
|
| Antidepressive Agents | 2 | 2020 | 189 | 0.190 |
Why?
|
| Spasms, Infantile | 1 | 2021 | 31 | 0.190 |
Why?
|
| Emergency Services, Psychiatric | 2 | 2007 | 15 | 0.190 |
Why?
|
| Psychotropic Drugs | 1 | 2021 | 84 | 0.180 |
Why?
|
| Mutation, Missense | 1 | 2021 | 107 | 0.180 |
Why?
|
| Longevity | 1 | 2021 | 90 | 0.180 |
Why?
|
| Anticonvulsants | 1 | 2021 | 131 | 0.180 |
Why?
|
| Psychotic Disorders | 1 | 2021 | 147 | 0.170 |
Why?
|
| Education, Medical | 1 | 2001 | 124 | 0.170 |
Why?
|
| Autistic Disorder | 1 | 2021 | 130 | 0.170 |
Why?
|
| Recurrence | 1 | 2021 | 694 | 0.170 |
Why?
|
| Students, Medical | 1 | 2001 | 181 | 0.160 |
Why?
|
| Patient Admission | 1 | 1999 | 84 | 0.160 |
Why?
|
| Buprenorphine | 1 | 2020 | 130 | 0.160 |
Why?
|
| Karyotype | 1 | 2017 | 18 | 0.160 |
Why?
|
| Karyotyping | 1 | 2017 | 96 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2017 | 43 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2001 | 396 | 0.150 |
Why?
|
| Social Justice | 1 | 2017 | 25 | 0.150 |
Why?
|
| Chronic Pain | 1 | 2020 | 170 | 0.150 |
Why?
|
| Social Behavior | 1 | 2017 | 81 | 0.150 |
Why?
|
| Chromosome Deletion | 1 | 2017 | 149 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2017 | 125 | 0.140 |
Why?
|
| Female | 12 | 2021 | 28547 | 0.140 |
Why?
|
| Ambulatory Care | 2 | 2012 | 236 | 0.130 |
Why?
|
| Depression | 3 | 2017 | 604 | 0.130 |
Why?
|
| Lithium | 2 | 1992 | 43 | 0.130 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 159 | 0.130 |
Why?
|
| Humans | 20 | 2021 | 54289 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 553 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 1999 | 425 | 0.120 |
Why?
|
| Phenotype | 1 | 2017 | 797 | 0.120 |
Why?
|
| Veterans | 2 | 2012 | 632 | 0.120 |
Why?
|
| Inpatients | 1 | 2016 | 203 | 0.120 |
Why?
|
| Mental Disorders | 1 | 1999 | 438 | 0.120 |
Why?
|
| Quality Improvement | 2 | 2013 | 236 | 0.110 |
Why?
|
| Psychiatry | 2 | 2007 | 113 | 0.110 |
Why?
|
| Substance-Related Disorders | 1 | 1999 | 679 | 0.110 |
Why?
|
| Disease Management | 1 | 2013 | 184 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 1 | 1991 | 52 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 1634 | 0.090 |
Why?
|
| Mice | 1 | 2021 | 6445 | 0.090 |
Why?
|
| Catatonia | 1 | 1989 | 11 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 1989 | 72 | 0.080 |
Why?
|
| Hospitals, Veterans | 4 | 2013 | 127 | 0.080 |
Why?
|
| Cerebellum | 1 | 1989 | 149 | 0.080 |
Why?
|
| Panic | 1 | 1987 | 5 | 0.070 |
Why?
|
| Disasters | 1 | 2007 | 16 | 0.070 |
Why?
|
| Mentally Ill Persons | 1 | 2007 | 17 | 0.070 |
Why?
|
| Male | 12 | 2020 | 27580 | 0.070 |
Why?
|
| Anxiety Disorders | 1 | 1987 | 134 | 0.070 |
Why?
|
| Fear | 1 | 1987 | 87 | 0.070 |
Why?
|
| Patient Transfer | 1 | 2007 | 103 | 0.070 |
Why?
|
| Animals | 1 | 2021 | 14671 | 0.060 |
Why?
|
| Patient Care Team | 3 | 2013 | 275 | 0.060 |
Why?
|
| Nortriptyline | 1 | 1984 | 4 | 0.060 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1985 | 181 | 0.060 |
Why?
|
| Ethanol | 1 | 1985 | 363 | 0.050 |
Why?
|
| Middle Aged | 6 | 2020 | 12965 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2007 | 493 | 0.050 |
Why?
|
| Prejudice | 1 | 2001 | 42 | 0.050 |
Why?
|
| Arkansas | 2 | 2007 | 2180 | 0.040 |
Why?
|
| Patient Care Planning | 2 | 2012 | 74 | 0.040 |
Why?
|
| Diagnosis-Related Groups | 1 | 1999 | 21 | 0.040 |
Why?
|
| Pain Management | 1 | 2020 | 156 | 0.040 |
Why?
|
| Brain | 1 | 1987 | 1418 | 0.040 |
Why?
|
| Curriculum | 1 | 2001 | 440 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 1999 | 301 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 115 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2020 | 6511 | 0.030 |
Why?
|
| Hobbies | 1 | 1994 | 2 | 0.030 |
Why?
|
| United States | 2 | 2012 | 5274 | 0.030 |
Why?
|
| Firearms | 1 | 1994 | 18 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1205 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2016 | 284 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 1992 | 349 | 0.030 |
Why?
|
| Delusions | 1 | 1993 | 9 | 0.030 |
Why?
|
| Spatial Behavior | 1 | 1993 | 11 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 1992 | 737 | 0.030 |
Why?
|
| Aged | 3 | 1999 | 9987 | 0.030 |
Why?
|
| Functional Laterality | 1 | 1993 | 94 | 0.030 |
Why?
|
| Lithium Carbonate | 1 | 1992 | 9 | 0.030 |
Why?
|
| Attention | 1 | 1993 | 183 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 107 | 0.030 |
Why?
|
| Community Mental Health Services | 1 | 2012 | 59 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2013 | 5557 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 74 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 244 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 276 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 1994 | 395 | 0.020 |
Why?
|
| Body Weight | 1 | 1991 | 586 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2012 | 397 | 0.020 |
Why?
|
| Radiography | 1 | 1989 | 527 | 0.020 |
Why?
|
| Alprazolam | 1 | 1987 | 4 | 0.020 |
Why?
|
| Carbamazepine | 1 | 1987 | 13 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 1987 | 74 | 0.020 |
Why?
|
| Telemedicine | 1 | 2012 | 472 | 0.020 |
Why?
|
| Chlordiazepoxide | 1 | 1985 | 9 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 1985 | 75 | 0.020 |
Why?
|
| Computers | 1 | 1984 | 48 | 0.020 |
Why?
|
| Kinetics | 1 | 1984 | 696 | 0.010 |
Why?
|
| Alcoholism | 1 | 1985 | 255 | 0.010 |
Why?
|
| Models, Biological | 1 | 1984 | 806 | 0.010 |
Why?
|
| Data Collection | 1 | 1994 | 310 | 0.010 |
Why?
|
| Schizophrenic Psychology | 1 | 1993 | 75 | 0.010 |
Why?
|
| Dopamine | 1 | 1993 | 198 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1993 | 357 | 0.010 |
Why?
|
| Schizophrenia | 1 | 1993 | 284 | 0.010 |
Why?
|
| Creatinine | 1 | 1991 | 160 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1992 | 639 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1993 | 1027 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1991 | 995 | 0.000 |
Why?
|
| Adolescent | 1 | 1993 | 6922 | 0.000 |
Why?
|